Genomic life science company EZZ Life Science has received FDA Approval in the US for nine of its products in the food category, allowing the company to access a broader consumer base in the country.
EZZ Life plans to use similar marketing strategies that have proven successful in other markets, focusing on online platforms to reach American consumers.
The nine products selected by the company due to their previous success and approved by the US FDA are:
- Children’s Essential Minerals
- Children’s Eye Health
- Bone Growth Chews
- Brain Focus
- Magnesium Plus
- Aloe Vera Probiotic Capsules
- Liver Detox
- Joint Energy Boost Tablets
- Men’s Performance
EZZ Life Science chairman Glenn Cross said entering the US market is a “monumental achievement’ for the company.
“This is a pivotal part of our plans for future growth, and we are excited about the opportunities this approval presents,” said Cross.
“We look forward to bringing our high-quality products to consumers in the United States and continuing to drive value for our shareholders.”
EZZ has established a wholly owned US subsidiary, EZZ Life Science Holdings (USA) Inc, to facilitate its operations in the US market.
